ASX - By Stock
|
A2M |
Re:
Closing price above $1.82 is crucial
|
|
milk2china
|
1.1K |
391K |
2 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
1.1K
|
391K
|
2
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
3 |
20/07/16 |
20/07/16 |
Charts
|
8.4K
|
3.1M
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
0 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Closing price above $1.82 is crucial
|
|
milk2china
|
1.1K |
391K |
7 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
1.1K
|
391K
|
7
|
|
Charts
|
PLS |
Re:
PLS chart
|
|
milk2china
|
2.5K |
967K |
2 |
20/07/16 |
20/07/16 |
Charts
|
2.5K
|
967K
|
2
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
0 |
20/07/16 |
20/07/16 |
Charts
|
8.4K
|
3.1M
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX
|
|
milk2china
|
147 |
49K |
1 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
147
|
49K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX
|
|
milk2china
|
147 |
49K |
0 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
147
|
49K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX
|
|
milk2china
|
147 |
49K |
4 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
147
|
49K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX
|
|
milk2china
|
147 |
49K |
10 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
147
|
49K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
US Hospital Announcement
|
|
milk2china
|
5 |
1.3K |
1 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
5
|
1.3K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Becoming a substantial holder-RAP.AX
|
|
milk2china
|
29 |
9.9K |
1 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
29
|
9.9K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
0 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
23
|
10K
|
0
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
2 |
20/07/16 |
20/07/16 |
Charts
|
8.4K
|
3.1M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
5 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
23
|
10K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
1 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
23
|
10K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
1 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
23
|
10K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
12 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
23
|
10K
|
12
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
0 |
19/07/16 |
19/07/16 |
Charts
|
8.4K
|
3.1M
|
0
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
7 |
19/07/16 |
19/07/16 |
Charts
|
8.4K
|
3.1M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
2 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
23
|
10K
|
2
|
|
ASX - By Stock
|
EDE |
Re:
Ann: EdenCrete - GDOT I-20 Field Trial Update-EDE.AX
|
|
milk2china
|
14 |
4.3K |
8 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
14
|
4.3K
|
8
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
1 |
19/07/16 |
19/07/16 |
Charts
|
8.4K
|
3.1M
|
1
|
|
ASX - By Stock
|
EDE |
Re:
Ann: EdenCrete - GDOT I-20 Field Trial Update-EDE.AX
|
|
milk2china
|
14 |
4.3K |
7 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
14
|
4.3K
|
7
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
5 |
19/07/16 |
19/07/16 |
Charts
|
8.4K
|
3.1M
|
5
|
|
ASX - By Stock
|
EDE |
Re:
US Infrastructure Report Card
|
|
milk2china
|
7 |
1.1K |
0 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
7
|
1.1K
|
0
|
|
ASX - By Stock
|
EDE |
Re:
US Infrastructure Report Card
|
|
milk2china
|
7 |
1.1K |
0 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
7
|
1.1K
|
0
|
|
ASX - By Stock
|
EDE |
Re:
US Infrastructure Report Card
|
|
milk2china
|
7 |
1.1K |
0 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
7
|
1.1K
|
0
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
5 |
19/07/16 |
19/07/16 |
Charts
|
8.4K
|
3.1M
|
5
|
|
ASX - By Stock
|
EDE |
Re:
Precision cut CNT's
|
|
milk2china
|
4 |
962 |
3 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
4
|
962
|
3
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
1 |
19/07/16 |
19/07/16 |
Charts
|
8.4K
|
3.1M
|
1
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
1 |
19/07/16 |
19/07/16 |
Charts
|
8.4K
|
3.1M
|
1
|
|
ASX - By Stock
|
EDE |
Re:
EDE Document Presentation standards
|
|
milk2china
|
3 |
906 |
0 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
3
|
906
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Brian Leedman Interview
|
|
milk2china
|
23 |
10K |
4 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
23
|
10K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
2 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
1 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
16 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
16
|
|
ASX - By Stock
|
EDE |
Re:
Ann: EdenCrete Update - MARTA Project Test Results-EDE.AX
|
|
milk2china
|
101 |
20K |
1 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
101
|
20K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
6 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
6
|
|
ASX - By Stock
|
EDE |
Re:
Ann: EdenCrete Update - MARTA Project Test Results-EDE.AX
|
|
milk2china
|
101 |
20K |
0 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
101
|
20K
|
0
|
|
ASX - By Stock
|
EDE |
Re:
Ann: EdenCrete Update - MARTA Project Test Results-EDE.AX
|
|
milk2china
|
101 |
20K |
0 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
101
|
20K
|
0
|
|
ASX - By Stock
|
GXY |
Re:
First stocks! Chose GXY..
|
|
milk2china
|
39 |
14K |
2 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
39
|
14K
|
2
|
|
ASX - By Stock
|
A2M |
Re:
Closing price above $1.82 is crucial
|
|
milk2china
|
1.1K |
391K |
2 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
1.1K
|
391K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
2 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
8 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
4 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
NPV - DFS
|
|
milk2china
|
30 |
11K |
2 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
30
|
11K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
3 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on US Clinical Study-RAP.AX
|
|
milk2china
|
236 |
82K |
1 |
18/07/16 |
18/07/16 |
ASX - By Stock
|
236
|
82K
|
1
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
milk2china
|
8.4K |
3.1M |
3 |
18/07/16 |
18/07/16 |
Charts
|
8.4K
|
3.1M
|
3
|
|